NCT01359462View on ClinicalTrials.gov

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

January 31, 2010

Conditions
Hepatic CirrhosisAscites
Interventions
DRUG

tolvaptan

"Drug: tolvaptan~tablet, 15mg, Qd, for 7 days."

Trial Locations (1)

200001

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY